Comparison | Standard Dose Model OR (95% CI) |
Unadjusted Dose Model OR (95% CI) |
Dose Adjusted Model OR (95% CI) |
Adalimumab vs Etanercept | 1.04 (0.51 to 2.02) | 0.86 (0.48 to 1.49) | 1.02 (0.53 to 1.91) |
Certolizumab vs Etanercept | 1.02 (0.44 to 2.32) | 0.98 (0.49 to 1.96) | 0.96 (0.44 to 2.08) |
Golimumab vs Etanercept | 1.03 (0.41 to 2.514) | 1.07 (0.51 to 2.19) | 0.94 (0.40 to 2.20) |
Abatacept vs Etanercept | 0.90 (0.38 to 2.10) | 0.90 (0.45 to 1.75) | 0.76 (0.33 to 1.75) |
Infliximab vs Etanercept | 1.81 (0.89 to 3.68) | 1.72 (1.02 to 2.91)* | 1.69 (0.89 to 3.20) |
Rituximab vs Etanercept | 2.11 (0.30 to 22.43) | 1.87 (0.90 to 3.94) | 1.31 (0.27 to 6.47) |
Anakinra vs Etanercept | 1.26 (0.45 to 3.34) | 1.21 (0.52 to 2.82) | 1.19 (0.47 to 3.01) |
Tocilizumab vs Etanercept | 1.41 (0.43 to 4.53) | 1.09 (0.52 to 2.28) | 1.15 (0.41 to 3.13) |
Certolizumab vs Adalimumab | 0.98 (0.43 to 2.33) | 1.14 (0.57 to 2.33) | 0.95 (0.44 to 2.12) |
Golimumab vs Adalimumab | 1.00 (0.40 to 2.49) | 1.24 (0.59 to 2.58) | 0.93 (0.39 to 2.22) |
Abatacept vs Adalimumab | 0.87 (0.37 to 2.09) | 1.05 (0.52 to 2.08) | 0.75 (0.32 to 1.76) |
Infliximab vs Adalimumab | 1.74 (0.86 to 3.70) | 2.00 (1.17 to 3.49)* | 1.66 (0.87 to 3.23) |
Rituximab vs Adalimumab | 2.04 (0.30 to 22.18) | 2.17 (1.04 to 4.74)* | 1.29 (0.26 to 6.55) |
Anakinra vs Adalimumab | 1.21 (0.44 to 3.32) | 1.41 (0.61 to 3.32) | 1.17 (0.46 to 3.03) |
Tocilizumab vs Adalimumab | 1.36 (0.42 to 4.43) | 1.27 (0.60 to 2.69) | 1.14 (0.41 to 3.15) |
Golimumab vs Certolizumab | 1.01 (0.35 to 2.78) | 1.09 (0.46 to 2.51) | 0.97 (0.37 to 2.57) |
Abatacept vs Certolizumab | 0.88 (0.33 to 2.31) | 0.91 (0.40 to 2.03) | 0.79 (0.30 to 2.05) |
Infliximab vs Certolizumab | 1.77 (0.75 to 4.22) | 1.75 (0.89 to 3.47) | 1.75 (0.79 to 3.84) |
Rituximab vs Certolizumab | 2.07 (0.28 to 23.37) | 1.89 (0.82 to 4.55) | 1.36 (0.26 to 7.27) |
Anakinra vs Certolizumab | 1.23 (0.40 to 3.65) | 1.24 (0.48 to 3.16) | 1.24 (0.44 to 3.46) |
Tocilizumab vs Certolizumab | 1.39 (0.39 to 4.85) | 1.11 (0.47 to 2.60) | 1.20 (0.39 to 3.59) |
Abatacept vs Golimumab | 0.87 (0.31 to 2.48) | 0.84 (0.37 to 1.94) | 0.81 (0.30 to 2.24) |
Infliximab vs Golimumab | 1.75 (0.70 to 4.53) | 1.62 (0.79 to 3.34) | 1.80 (0.76 to 4.28) |
Rituximab vs Golimumab | 2.05 (0.27 to 24.09) | 1.76 (0.73 to 4.30) | 1.38 (0.26 to 7.74) |
Anakinra vs Golimumab | 1.22 (0.38 to 3.90) | 1.14 (0.44 to 3.02) | 1.27 (0.43 to 3.81) |
Tocilizumab vs Golimumab | 1.36 (0.37 to 5.12) | 1.03 (0.43 to 2.49) | 1.23 (0.38 to 3.95) |
Infliximab vs Abatacept | 2.01 (0.87 to 4.77) | 1.92 (1.01 to 3.71)* | 2.21 (0.98 to 5.09) |
Rituximab vs Abatacept | 2.35 (0.32 to 26.5) | 2.07 (0.91 to 4.92) | 1.72 (0.32 to 9.40) |
Anakinra vs Abatacept | 1.40 (0.45 to 4.32) | 1.35 (0.53 to 3.47) | 1.57 (0.53 to 4.68) |
Tocilizumab vs Abatacept | 1.57 (0.44 to 5.65) | 1.22 (0.53 to 2.84) | 1.51 (0.47 to 4.78) |
Rituximab vs Infliximab | 1.16 (0.17 to 12.87) | 1.09 (0.53 to 2.26) | 0.78 (0.16 to 3.85) |
Anakinra vs Infliximab | 0.70 (0.24 to 1.91) | 0.71 (0.31 to 1.60) | 0.71 (0.28 to 1.80) |
Tocilizumab vs Infliximab | 0.78 (0.24 to 2.54) | 0.64 (0.31 to 1.30) | 0.68 (0.24 to 1.88) |
Anakinra vs Rituximab | 0.59 (0.05 to 4.61) | 0.65 (0.24 to 1.68) | 0.91 (0.16 to 5.16) |
Tocilizumab vs Rituximab | 0.67 (0.05 to 5.67) | 0.59 (0.24 to 1.40) | 0.88 (0.15 to 5.20) |
Tocilizumab vs Anakinra | 1.12 (0.29 to 4.49) | 0.90 (0.34 to 2.41) | 0.97 (0.28 to 3.22) |